;)
Ribon´s Challenge
Boston-based biotechnology company operating under a Series A raise focused on oncology and immune mediated conditions. The management team required operational and strategic feedback on their clinical-stage development programs to supplement and challenge their internal thinking and plans to optimize next steps of ongoing and planned studies.
As a privately held, small biotech company with 2 clinical-stage programs each in oncology and inflammatory diseases, we partnered with Adnovate Clinical to leverage their strong scientific and strategic support. We tapped into their medical, translational, regulatory, statistical, and operational capabilities to supplement our clinical development function and pressure test our scientific and operational plans on an as needed basis. Their highly qualified and organized team helped us understand the treatment and competitive landscape which refined our clinical development plan (CDP) and clinical trial designs.
Sudha Parasuraman | CMO.
Adnovate Clinical’s Solution
Using a cross functional team of seasoned experts, Adnovate conducted a detailed assessment of the scientific rationale and literature, assessed novel challenge-based biomarker approaches to assess target engagement and pharmacodynamic effects, designed alternate studies and clinical plans, and assessed clinical operational strategies being used on ongoing studies.
